Home › PharmaCyte Biotech Discusses Major Milestones Ahead of Phase 2b Clinical Trial in Pancreatic Cancer
 

Keywords :   


PharmaCyte Biotech Discusses Major Milestones Ahead of Phase 2b Clinical Trial in Pancreatic Cancer

2015-09-15 15:58:58| Biotech - Topix.net

PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-BoxA , discussed today some of the major "milestone" tasks that must be completed to begin its Phase 2b clinical trial in pancreatic cancer. The trial will test the effectiveness and safety of PharmaCyte Biotech's pancreatic cancer treatment.

Tags: major trial phase ahead

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.04Post Office paid widow in instalments for silence
26.04Kimberly-Clark, Amcor Develop 30% Recycled Content Packaging
26.04IST America showcasing new products at RadTech UV&EB Technology & Conference
26.04Movistar Plus+ to create real-time short-form sports video with WSC Sports
26.04Casella Waste Systems Shows Strong Start in Q1 2024
26.04PPG Earns EcoVadis Gold Rating for Sustainability Practices
26.04Maesa Taps Molly Kennedy VP of Marketing of Kristin Ess Hair
26.04SeaChange to instead be acquired by Enghouse
More »